Oral Poliomyelitis vaccine (LA) Solution

The Oral Poliovirus Vaccine (OPV), also known as Oral Polio Vaccine (LA) Solution, was a widely used vaccine to prevent poliomyelitis (polio) infection. However, it's no longer routinely administered in many countries, including the United States, due to the risk of a rare side effect [1, 2]. Here's a breakdown of what it was and why it's not commonly used anymore:

Function:

• OPV was a live attenuated vaccine. This means it contained a weakened form of the poliovirus that could stimulate the body's immune system to develop antibodies against polio.
• Unlike an inactivated vaccine (which uses a killed virus), OPV offered the advantage of herd immunity. After receiving the vaccine, a person would develop immunity and also briefly shed the weakened virus in their stool. This indirect exposure could help build immunity in unvaccinated people around them, creating a broader shield against the disease.

Historical Significance:

• OPV played a crucial role in drastically reducing polio cases worldwide. Mass vaccination campaigns with OPV were instrumental in polio eradication efforts [3].

Why Not Used Routinely Anymore:

• While highly effective, OPV carried a very small risk of causing vaccine-associated polio paralysis (VAPP) [1, 2]. VAPP occurred when the weakened vaccine virus in the OPV mutated and regained its ability to cause illness in some rare instances.
• With improved sanitation and widespread use of the inactivated polio vaccine (IPV), the risk of natural polio infection became very low in many countries. This made the minimal risk of VAPP associated with OPV less justifiable.

Current Use of Polio Vaccine:

• The inactivated polio vaccine (IPV) is the preferred method of polio vaccination in most countries. IPV is a safe and effective vaccine that doesn't carry the risk of VAPP [2].